Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06088654. IPD Sharing: NO. Countries: 3. Publications: 0.
Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00007865. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JMT601 in Participants With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06725524. IPD Sharing: NO. Countries: 1. Publications: 0.
Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01719250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects
ClinicalTrials.gov study NCT01205737. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions
ClinicalTrials.gov study NCT06720207. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT05424822. IPD Sharing: YES. Countries: 8. Publications: 0.
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06295549. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases
ClinicalTrials.gov study NCT00538551. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation and Expansion Study of CPO107 for Patients with Advanced CD20-positive Non-Hodgkins Lymphoma
ClinicalTrials.gov study NCT04853329. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19 CAR-T Therapy for Patients With B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT04661020. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00440388. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00016094. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).
ClinicalTrials.gov study NCT05260957. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00044551. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003605. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01939327. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00006039. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05312801. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00031902. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.